Cargando…

CA125 effects on humoral immunosuppression

Detalles Bibliográficos
Autores principales:	Kline, J. Bradford, Nicolaides, Nicholas C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5680546/ https://www.ncbi.nlm.nih.gov/pubmed/29016358 http://dx.doi.org/10.18632/aging.101301

Ejemplares similares

Block-Removed Immunoglobulin Technology to enhance rituximab effector function by counteracting CA125-mediated immunosuppression
por: Grasso, Luigi, et al.
Publicado: (2022)

NAV-001, a high-efficacy antibody-drug conjugate targeting mesothelin with improved delivery of a potent payload by counteracting MUC16/CA125 inhibitory effects
por: Nicolaides, Nicholas C., et al.
Publicado: (2023)

CA125 suppresses amatuximab immune-effector function and elevated serum levels are associated with reduced clinical response in first line mesothelioma patients
por: Nicolaides, Nicholas C., et al.
Publicado: (2018)

Tumor antigen CA125 suppresses antibody-dependent cellular cytotoxicity (ADCC) via direct antibody binding and suppressed Fc-γ receptor engagement
por: Kline, James Bradford, et al.
Publicado: (2017)

Is CA125 useful in monitoring patients with platinum-resistant ovarian cancer?
por: Rustin, G. J. S., et al.
Publicado: (2016)

Preoperative CA-125 in low-grade endometrial cancer: risk stratification and implications for treatment
por: Kwon, Janice S.
Publicado: (2019)

Elevated CA-125 as Humoral Biomarker of Congestive Heart Failure: Illustrative Cases and a Short Review of Literature
por: Frigy, Attila, et al.
Publicado: (2020)

Peritoneal trauma releases CA125?
por: Redman, C. W., et al.
Publicado: (1988)

Exploring the Glycosylation of Serum CA125
por: Saldova, Radka, et al.
Publicado: (2013)

The Effect of Surgical Intervention of Endometriosis to CA-125 and Pain
por: Abdul Karim, Abdul Kadir, et al.
Publicado: (2020)

The Humoral Theory of Transplantation
por: Ravindranath, Mepur H., et al.
Publicado: (2017)

Oncological markers CA-125, CA 19-9 and endometriosis
por: Fiala, Ludek, et al.
Publicado: (2018)

Massive Elevation of CA-125 in Chylous Ascites
por: Orbay, Tuğçe Merve, et al.
Publicado: (2023)

CA-125 is not a useful marker in metastatic breast cancer.
por: Seckl, M. J., et al.
Publicado: (1992)

Asthma prevalence and humoral immune response in Somali immigrants in the US: implications for the hygiene hypothesis
por: Butler, Christopher C, et al.
Publicado: (2013)

Humor and sympathy in medical practice
por: Hardy, Carter
Publicado: (2019)

Elevated CA125 levels in patients with metastatic breast carcinoma.
por: Perey, L., et al.
Publicado: (1990)

How to Use CA-125 More Effectively in the Diagnosis of Deep Endometriosis
por: Oliveira, Marco Aurelio Pinho, et al.
Publicado: (2017)

Rising CA-125 (Cancer Antigen 125) Levels: Cancer Recurrence or a Vaccine Reaction?
por: Parkash, Jasmita, et al.
Publicado: (2023)

Modes of immunosuppression in glioblastoma microenvironment
por: Lehtipuro, Suvi, et al.
Publicado: (2019)

Chronic Lymphocytic Leukemia-Induced Humoral Immunosuppression: A Systematic Review
por: Grywalska, Ewelina, et al.
Publicado: (2020)

Rabies, Still Neglected after 125 Years of Vaccination
por: Bourhy, Hervé, et al.
Publicado: (2010)

CA125 in ovarian tumour tissue at second laparotomy.
por: Maughan, T. S., et al.
Publicado: (1989)

Expression of CA125 in pancreatic carcinoma and chronic pancreatitis.
por: Macdonald, F., et al.
Publicado: (1988)

HE4, CA-125, and cystic ovarian mass
por: Wiwanitkit, Viroj
Publicado: (2012)

Elevated CA 125 in a CASE of Leaking Endometrioma
por: Rao, Svetha, et al.
Publicado: (2018)

Clinical utility of CA-125 in the management of uterine carcinosarcoma
por: Matsuo, Koji, et al.
Publicado: (2018)

CA125 and Ovarian Cancer: A Comprehensive Review
por: Charkhchi, Parsa, et al.
Publicado: (2020)

Localized Hepatosplenic Sarcoidosis with an Elevated Serum CA-125 Level
por: Herati, Ramin S., et al.
Publicado: (2010)

The prognostic value of pretreatment CA-125 levels and CA-125 normalization in ovarian clear cell carcinoma: a two-academic-institute study
por: Bai, Huimin, et al.
Publicado: (2016)

The Clinical Significance of CEA, CA19–9, and CA125 in Management of Appendiceal Adenocarcinoma
por: Yousef, Abdelrahman, et al.
Publicado: (2023)

CA125/MUC16 Is Dispensable for Mouse Development and Reproduction
por: Cheon, Dong-Joo, et al.
Publicado: (2009)

Psychological Investigations of Humor and Laughter: Honoring the Research Contributions of Professor Rod Martin: Opening Comments
por: Kuiper, Nicholas A.
Publicado: (2016)

Tumour-associated trypsin inhibitor (TATI) and cancer antigen 125 (CA 125) in mucinous ovarian tumours.
por: Mogensen, O., et al.
Publicado: (1990)

Application of Various Optical and Electrochemical Nanobiosensors for Detecting Cancer Antigen 125 (CA-125): A Review
por: Pourmadadi, Mehrab, et al.
Publicado: (2023)

Immunosuppression by viral N proteins
por: Chen, Jidang, et al.
Publicado: (2017)

Immunosuppressive therapy in dermatology and PML
por: Sterry, Wolfram, et al.
Publicado: (2009)

Cutaneous bacteria induce immunosuppression
por: Skabytska, Yuliya, et al.
Publicado: (2015)

Immunosuppression via Tenascin-C
por: Bellone, Matteo, et al.
Publicado: (2015)

The paradox of immunosuppressants and COVID-19
por: Cheng, Guang-Shing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r0rsunr93ma8259gic8m4stesl